Literature DB >> 25307199

Coronary computed tomographic angiographic findings in patients with Kawasaki disease.

B Kelly Han1, Andrew Lesser2, Kristi Rosenthal2, Kirsten Dummer3, Katharine Grant4, Marc Newell2.   

Abstract

Kawasaki disease (KD) is the leading cause of acquired coronary disease in children and may lead to subsequent myocardial ischemia and infarction. Because coronary computed tomographic angiography (CTA) is the most sensitive noninvasive test in patients with atherosclerosis, the aim of this study was to retrospectively evaluate coronary CTA performed in patients with KD for aneurysm, stenosis, and calcified and noncalcified coronary artery disease (CAD). Clinical histories and prior stress and imaging test results were reviewed. Thirty-two patients underwent coronary CTA for KD, and 385 coronary segments were evaluated. Twenty-three of 32 patients had ≥1 diseased coronary segment. There were 20 aneurysms, 7 lesions, and 75 segments (20%) with nonobstructive CAD (16% noncalcified, 2% calcified, and 2% mixed). All nonobstructive and obstructive CAD was in patients with histories of acute-phase coronary artery dilatation or aneurysm (echocardiographic z score 4 to 44), and were almost always associated with normal stress imaging test results on follow-up. No lesion or CAD was found in coronary computed tomographic angiographic studies performed in a control group referred for other indications (n = 32, 422 segments evaluated). The median coronary computed tomographic angiographic dose-length product was 59 mGy cm (interquartile range 32 to 131), the median unadjusted radiation dose was 0.8 mSv (interquartile range 0.4 to 1.8), and the median age- and size-adjusted radiation dose was 1.3 mSv (interquartile range 0.7 to 2.3). In conclusion, high-risk patients with histories of KD had nonobstructive and obstructive CAD not visualized by other noninvasive imaging tests. In properly selected high-risk patients with KD, coronary CTA may identify a subset at increased risk for future coronary pathology who may benefit from medical therapy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25307199     DOI: 10.1016/j.amjcard.2014.09.004

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Assessment of Coronary Artery Aneurysms Caused by Kawasaki Disease Using Transluminal Attenuation Gradient Analysis of Computerized Tomography Angiograms.

Authors:  Noelia Grande Gutierrez; Olga Shirinsky; Nina Gagarina; Galina Lyskina; Ryuji Fukazawa; Shunichi Ogawa; Jane C Burns; Alison L Marsden; Andrew M Kahn
Journal:  Am J Cardiol       Date:  2017-05-30       Impact factor: 2.778

Review 2.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

Review 3.  The emergence of Kawasaki disease in India and China.

Authors:  Fuyong Jiao; Ankur Kumar Jindal; Vignesh Pandiarajan; Raju Khubchandani; Nutan Kamath; Tapas Sabui; Rakesh Mondal; Priyankar Pal; Surjit Singh
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.